Patents by Inventor Yifei SHEN

Yifei SHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Iron-based metal powder for ultra-high-speed laser cladding, its preparation method and its application
    Patent number: 11932927
    Abstract: An iron-based metal powder for ultra-high-speed laser cladding comprising chemical composition and mass percentage of the metal powder of: C 0.6˜1.0%, Cr 17.0˜20.0%, Ni 5.0˜6.5%, Mn 2.0˜4.0%, Mo 1.0˜1.5%, Ti 4.0˜6.0%, B 1.0˜1.5%, N 0.08˜0.15%, Si?0.5%, P?0.030%, S?0.030%, balance of Fe and unavoidable impurities, wherein the particle size of the metal powder is 15˜65 ?m, the fluidity is 16˜20 s/50 g.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: March 19, 2024
    Assignee: CHINA MACHINERY INSTITUTE OF ADVANCED MATERIALS (ZHENGZHOU) CO., LTD.
    Inventors: Miaohui Wang, Xueyuan Ge, Borui Du, Bowen Shen, Yifei Xu, Ning Xiao, Sheng Hao
  • ERK inhibitor and use thereof
    Patent number: 11466013
    Abstract: Disclosed are a compound (as shown in formula I) as an extracellular signal-regulated kinase (ERK) inhibitor, a pharmaceutical composition thereof, a preparation method therefor, and use thereof in treating ERK-mediated diseases. Said compound plays a role by regulating a plurality of processes such as cell proliferation, apoptosis, migration and angiogenesis.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: October 11, 2022
    Assignee: Betta Pharmaceuticals Co., Ltd
    Inventors: Hao Wu, Wei Gu, Xiaojing Tang, Wei Wang, Bo Zhan, Dongjie Feng, Yongxin Ke, Zhongyan Chen, Yifei Shen, Wenmao Wu, Xintao Zhao, Hong Lan, Jiabing Wang, Lieming Ding
  • ERK INHIBITOR AND USE THEREOF
    Publication number: 20210261552
    Abstract: Disclosed are a compound (as shown in formula I) as an extracellular signal-regulated kinase (ERK) inhibitor, a pharmaceutical composition thereof, a preparation method therefor, and use thereof in treating ERK-mediated diseases. Said compound plays a role by regulating a plurality of processes such as cell proliferation, apoptosis, migration and angiogenesis.
    Type: Application
    Filed: June 6, 2019
    Publication date: August 26, 2021
    Applicant: Betta Pharmaceuticals Co., LTD
    Inventors: Hao WU, Wei GU, Xiaojing TANG, Wei WANG, Bo ZHAN, Dongjie FENG, Yongxin KE, Zhongyan CHEN, Yifei SHEN, Wenmao WU, Xintao ZHAO, Hong LAN, Jiabing WANG, Lieming DING